Andric N

ORCID: 0000-0003-1025-8358 · 4 papers in corpus
2026
Perfluorooctane sulfonate (PFOS) in follicular fluid and human granulosa cell dysfunction: a physiologically based toxicokinetic model translation of long-term low-level in vitro exposure data.
Human reproduction open ·doi:10.1093/hropen/hoag029

Study questionAre bioactive human-equivalent doses (HEDs) of perfluorooctane sulfonate (PFOS), derived from long-term low-level in vitro exposure of human granulosa cells comparable to HEDs inferred from follicular fluid PFOS concentrations…

2025
The Effectiveness of the GnRH Agonist/Antagonist Protocols for Different Poseidon Subgroups of Poor Ovarian Responders.
Journal of clinical medicine ·doi:10.3390/jcm14062026

Background/Objectives: Poor responder patients represent the greatest challenge in ART. An inadequate response to COS strongly correlates with a reduced chance of conception. A novel classification of poor responders overcame a deficiency i…

2023
The Prediction of IVF Outcomes with Autologous Oocytes and the Optimal MII Oocyte/Embryo Number for Live Birth at Advanced Maternal Age.
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina59101799

Background and Objectives: Delayed childbearing in advanced age might be associated with a low prognosis for achieving pregnancy. Therefore, it is important to establish a predictive tool that will optimize the likelihood of a live birth at…

2022
Mapping DEHP to the adverse outcome pathway network for human female reproductive toxicity.
Archives of toxicology ·doi:10.1007/s00204-022-03333-y

Adverse outcome pathways (AOPs) and AOP networks are tools for mechanistic presentation of toxicological effects across different levels of biological organization. These tools are used to better understand how chemicals impact human health…